Are you a US healthcare professional?

The information contained in this website is intended for US healthcare professionals only.

No insurance/denied coverage

  • Myovant Patient Assistance Program

Myovant Patient Assistance Program

The Myovant Patient Assistance Program can provide Myfembree at no cost to eligible patients with a coverage denial or no insurance coverage

The Myovant Patient Assistance Program can provide a supply of Myfembree as long as a patient can meet and maintain eligibility requirements. Free medication supply is fulfilled by TC Script, a noncommerical dispensing pharmacy. Additional terms and conditions apply and can be found below.

The Myovant Sciences Patient Assistance Program (“Program”) provides Myfembree at no cost to eligible patients who are prescribed Myfembree for an FDA-approved indication. Patients and prescribers must complete the Myfembree Support Program enrollment form, and prescribers must provide a Patient Assistance Program prescription. Patients must meet Program eligibility requirements, which include, but are not limited to, lack of insurance coverage for Myfembree, financial criteria and income evaluation, and patients must be residents of the United States and US Territories. Program requires annual re-evaluation and re-enrollment for continued participation. Patients may be asked to reverify insurance coverage status during the course of the Program. Patient and participating prescribers agree not to seek reimbursement for all, or any part of, the free product received by the patient through this Program. Patients may not count the free product received from the Myfembree Support Program as an expense incurred for purposes of determining out-of-pocket costs for any plan, including true out-of-pocket costs (“TrOOP”) for purposes of calculating the out-of-pocket threshold for Medicare Part D plans. Government health insured patients who meet the Program eligibility criteria are eligible to receive free product for the entire coverage year, and Myovant Sciences will notify patients’ government health insurance plans that the patient is enrolled in the Program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Other limitations may apply. Myovant Sciences reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

Enrolling in the Myfembree® Support Program

Call to speak to dedicated support staff who will guide you through the enrollment process.

1-833-MYFEMBREE (1-833-693-3627), 8 AM–8 PM ET, Monday–Friday.

Please see your prescribing doctor or call the Myfembree® Support Program for enrollment assistance. Once you are enrolled, the support program team can provide specific information to help you understand your insurance benefits and coverage for Myfembree.

USE

Myfembree (relugolix, estradiol, and norethindrone acetate) is used to control heavy menstrual bleeding due to uterine fibroids in premenopausal women ≥18 years of age. It should not be taken for more than 24 months.

IMPORTANT SAFETY INFORMATION

Boxed Warning: Cardiovascular conditions: Myfembree may increase your chances of heart attack, stroke, or blood clots, especially if you are >35 years old, smoke, and have uncontrolled high blood pressure. Stop taking Myfembree and call your healthcare provider (HCP) or go to the nearest emergency room right away if you have: leg pain or swelling that won’t go away; sudden shortness of breath; double vision, bulging of the eyes, sudden partial or complete blindness; pain or pressure in your chest, arm, or jaw; sudden, severe headache unlike your usual headaches; weakness or numbness in an arm or leg, or trouble speaking.

IMPORTANT SAFETY INFORMATION

Boxed Warning: Cardiovascular conditions: Myfembree may increase your chances of heart attack, stroke, or blood clots, especially if you are >35 years old, smoke, and have uncontrolled high blood pressure. Stop taking Myfembree and call your healthcare provider (HCP) or go to the nearest emergency room right away if you have: leg pain or swelling that won’t go away; sudden shortness of breath; double vision, bulging of the eyes, sudden partial or complete blindness; pain or pressure in your chest, arm, or jaw; sudden, severe headache unlike your usual headaches; weakness or numbness in an arm or leg, or trouble speaking.

USE

Myfembree (relugolix, estradiol, and norethindrone acetate) is used to control heavy menstrual bleeding due to uterine fibroids in premenopausal women ≥18 years of age. It should not be taken for more than 24 months.

USE

Myfembree (relugolix, estradiol, and norethindrone acetate) is used to control heavy menstrual bleeding due to uterine fibroids in premenopausal women ≥18 years of age. It should not be taken for more than 24 months.

IMPORTANT SAFETY INFORMATION

Boxed Warning: Cardiovascular conditions: Myfembree may increase your chances of heart attack, stroke, or blood clots, especially if you are >35 years old, smoke, and have uncontrolled high blood pressure. Stop taking Myfembree and call your healthcare provider (HCP) or go to the nearest emergency room right away if you have: leg pain or swelling that won’t go away; sudden shortness of breath; double vision, bulging of the eyes, sudden partial or complete blindness; pain or pressure in your chest, arm, or jaw; sudden, severe headache unlike your usual headaches; weakness or numbness in an arm or leg, or trouble speaking.

Do not take Myfembree if you:

  • have or have had blood clots in your legs, lungs, or eyes; a stroke or heart attack; a problem that makes your blood clot more than normal; blood circulation disorders; certain heart valve or rhythm problems that can cause blood clots to form in the heart; high blood pressure not well controlled by medicine; diabetes with kidney, eye, nerve, or blood vessel damage; certain kinds of severe migraine headaches with aura, numbness, weakness or changes in vision or migraine headaches if you are >35 years old; breast cancer or any cancer that is sensitive to female hormones; osteoporosis; undiagnosed vaginal bleeding; liver problems;
  • smoke and are >35 years old;
  • have had a serious allergic reaction (e.g., swelling of your face, lips, mouth or tongue, trouble breathing, skin rashes, redness) or swelling or an allergic reaction to relugolix, estradiol, norethindrone or any of the ingredients in Myfembree.

Bone Loss (Decreased Bone Mineral Density [BMD]): While taking Myfembree, your estrogen levels may be low, which can lead to BMD loss. If this happens, your BMD may improve after you stop Myfembree, but complete recovery may not occur. It is unknown if these BMD changes could increase your risk for broken bones as you age. For this reason,you should not take Myfembree for more than 24 months. Your HCP may order an X-ray test called a DXA scan to check your BMD when you start Myfembree and periodically after.

Suicidal thoughts and behavior and worsening of mood. Call your HCP or get emergency medical help right away if you have any of these symptoms, especially if they are new, worse, or bother you: thoughts about suicide or dying, attempts to commit suicide, new or worse depression or anxiety, other unusual changes in behavior or mood. Pay attention to any changes, especially sudden changes in your mood, behaviors, thoughts, or feelings.

Abnormal liver tests. Call your HCP right away if you have any of these signs and symptoms of liver problems: jaundice, dark amber-colored urine, feeling tired, nausea and vomiting, generalized swelling, right upper stomach area pain, bruising easily.

High blood pressure. See your HCP to check your blood pressure regularly.

Effects on Pregnancy: Do not take Myfembree if you are trying to become or are pregnant. It may increase the risk of early pregnancy loss.If you think you are pregnant, stop taking Myfembree right away and call your HCP. Myfembree can cause decreased or no menstrual bleeding, making it hard to know if you are pregnant. Watch for other signs of pregnancy like breast tenderness, weight gain, and nausea. Myfembree does not prevent pregnancy. You will need to use effective non-hormonal methods of birth control (e.g., condoms, spermicide) during and for 1 week after stopping Myfembree. Do not take hormonal birth control such as birth control pills, because they may increase side effects and Myfembree may not work as well.

Uterine fibroid prolapse or expulsion. Fibroids can come out completely or partially through the vagina. Call your HCP right away if you have increased bleeding from the vagina, which can be serious, or cramping.

Severe allergic reactions. Myfembree may cause swelling of your face, lips, mouth or tongue, trouble breathing, skin rashes, and redness.

The most common side effects are hot flushes, increased sweating, night sweats, abnormal vaginal bleeding (bleeding that lasts too long, is too much, or is unexpected), hair loss or thinning, decreased interest in sex.

These are not all the possible side effects of Myfembree. Call your doctor for medical advice about side effects.

Tell your HCP about all your prescription and over-the-counter medicines, vitamins, and herbal supplements. If you take oral P-gp inhibitors, take Myfembree first and wait at least 6 hours before taking the P-gp inhibitor. Ask your HCP if you are not sure if you are taking this type of medicine.

Tell your HCP if you are breastfeeding. Myfembree may pass into your breast milk.

Please see full Prescribing Information, including BOXED WARNINGand Patient Information

You Are Now Leaving Myfembree.com

The information provided on myfembreehcp.com is intended only for healthcare professionals in the United States.
Would you like to continue?